Randomised controlled trial to investigate optimal antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: a study protocol of the OPTIMA-AF trial
This study received approval from the Certified Review Board of Osaka University (a certified research ethics committee by the Japanese Clinical Research Act). The findings will be disseminated through peer-reviewed publications and conference presentations.
Trial registration number
Japan Registry of Clinical Trials: jRCTs051190053; Pre-results.
Source: BMJ Open - Category: General Medicine Authors: Sotomi, Y., Kozuma, K., Kashiwabara, K., Higuchi, Y., Ando, K., Morino, Y., Ako, J., Tanabe, K., Muramatsu, T., Nakazawa, G., Hikoso, S., Sakata, Y., on behalf of the OPTIMA-AF Investigators Tags: Open access, Cardiovascular medicine Source Type: research
More News: Angioplasty | Atrial Fibrillation | Bleeding | Cardiology | Cardiovascular | Clinical Trials | Conferences | Coronary Angioplasty | General Medicine | Heart | Heart Attack | Japan Health | Medical Ethics | Percutaneous Coronary Intervention | Stroke | Study | Thrombosis